Full Press Release Details
LONDON, Oct. 24, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today announced that André-Michel Ballester, Chief Executive Officer of LivaNova, and Vivid Sehgal, Chief Financial Officer of LivaNova, will both be participating in a discussion at the Credit Suisse Healthcare Conference on Tuesday, November 8, 2016.
The discussion is scheduled to begin at 11:00 a.m. Mountain Standard Time on Tuesday, November 8, 2016. It will be available to all interested parties through a live audiocast accessible via the investor relations section of LivaNova's website atwww.livanova.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. A replay of the webcast will be available on the LivaNova website approximately 24 hours after the live presentation for 90 days after the event.
About LivaNovaLivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems.
The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K.
For more information, please visitwww.livanova.com, or contact:Investor Relations and MediaKaren KingVice President, Investor Relations & Corporate CommunicationsPhone: +1 (281) 228-7262Fax: +1 (281) 218-9332e-mail:corporate.communications@livanova.com